Reduced Serum Circulation of Cell-Free DNA Following Chemotherapy in Breast Cancer Patients

Reduced Serum Circulation of Cell-Free DNA Following Chemotherapy in Breast Cancer Patients

Breast cancer is the most common malignancy in women, with alarming mortalities. Neoadjuvant treatments employ chemotherapy to shrink tumours to a well-defined size for a better surgical outcome. The current means of assessing effectiveness of chemotherapy management are imprecise. We previously sho...

Full description

Bibliographic Details
Main Authors: Evelyn Adusei, John Ahenkorah, Nii Armah Adu-Aryee, Kevin Kofi Adutwum-Ofosu, Emmanuel Ayitey Tagoe, Nii Koney-Kwaku Koney, Emmanuel Nkansah, Nii Ayite Aryee, Richard Michael Blay, Bismarck Afedo Hottor, Joe-Nat Clegg-Lamptey, Benjamin Arko-Boham
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Medical Sciences
Subjects:
circulating cell-free DNA
cfDNA
breast cancer
chemotherapy
biomarker
Online Access:https://www.mdpi.com/2076-3271/9/2/37

Internet

https://www.mdpi.com/2076-3271/9/2/37

Similar Items